{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:19:15Z","timestamp":1792880355959,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.jaci.2004.10.042","type":"journal-article","created":{"date-parts":[[2005,1,4]],"date-time":"2005-01-04T07:16:50Z","timestamp":1104823010000},"page":"118-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":253,"title":["Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment"],"prefix":"10.1016","volume":"115","author":[{"given":"Santa Jeremy","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Abelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2004.10.042_bib1","series-title":"Immunology and immunopathology of the eye","first-page":"362","article-title":"Histamine in the eye","author":"Abelson","year":"1979"},{"key":"10.1016\/j.jaci.2004.10.042_bib2","first-page":"594","article-title":"Unilateral blepharochalasis","volume":"18","author":"Langley","year":"1987","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.jaci.2004.10.042_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/1523-1747.ep12456193","article-title":"Chronic heliodermatitis: a morphologic evaluation of chronic actinic dermal damage with emphasis on the role of mast cells","volume":"90","author":"Lavker","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.10.042_bib4","doi-asserted-by":"crossref","unstructured":"Berger WE, Lanier BQ, Abelsn MB. Evaluation of the effect of an adjuvant therapy of olopatadine HCl 0.1% ophthalmic solution on quality of life of patients with allergic rhinitis using systemic and\/or nasal therapy. Presented at: ACAAI; November 12-17, 2004; Boston, Mass.","DOI":"10.1016\/S1081-1206(10)61155-6"},{"key":"10.1016\/j.jaci.2004.10.042_bib5","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0149-2918(02)80080-7","article-title":"A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model","volume":"24","author":"Crampton","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaci.2004.10.042_bib6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0149-2918(03)80115-7","article-title":"A randomized, double blind, parallel group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis","volume":"25","author":"Abelson","year":"2003","journal-title":"Clin Ther"},{"issue":"Pt B","key":"10.1016\/j.jaci.2004.10.042_bib7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/978-1-4615-0717-8_149","article-title":"Ocular drying associated with oral antihistamines (loratadine) in the normal population-an evaluation of exaggerated dose effect","volume":"506","author":"Welch","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaci.2004.10.042_bib8","unstructured":"Gupta G, Ousler GW, Pollard SD, Abelson MB. The comparative ocular drying effects between Claritin and Zyrtec in normal adults. ARVO Abstract no. 70. Available at: www.arvo.org."},{"key":"10.1016\/j.jaci.2004.10.042_bib9","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0161-6420(95)30768-3","article-title":"Histaminase activity in patients with vernal keratoconjunctivitis","volume":"102","author":"Abelson","year":"1995","journal-title":"Ophthalmology"},{"issue":"suppl","key":"10.1016\/j.jaci.2004.10.042_bib10","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/01.ico.0000136671.50777.fe","article-title":"Roles of chemokines in ocular allergy and possible therapeutic strategies","volume":"23","author":"Miyazaki","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.jaci.2004.10.042_bib11","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jaci.2003.09.022","article-title":"Expression profiling: opportunities and pitfalls and impact on the study and management of allergic diseases","volume":"112","author":"Ono","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.10.042_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00130832-200310000-00010","article-title":"Animal models of ocular allergy","volume":"3","author":"Bundoc","year":"2003","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.10.042_bib13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1067\/mai.2003.1594","article-title":"Chemokines: roles in leukocyte development, trafficking, and effector function","volume":"111","author":"Ono","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.10.042_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000053709","article-title":"Genetics of allergic disease: evidence for organ-specific susceptibility genes","volume":"124","author":"Nishimura","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.10.042_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2745.2003.01616.x","article-title":"Vernal keratoconjunctivitis: evidence for immunoglobulin E-dependent and immunoglobulin E-independent eosinophilia","volume":"33","author":"Ono","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2004.10.042_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0091-6749(97)70279-3","article-title":"T-cell cytokines in chronic allergic eye disease","volume":"100","author":"Metz","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.10.042_bib17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.0022-202X.2004.23428.x","article-title":"Transforming growth factor-beta1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1a dendritic cells in vitro","volume":"123","author":"Allam","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.10.042_bib18","first-page":"3850","article-title":"Prevention of acute allergic conjunctivitis and late-phase inflammation with immunostimulatory DNA sequences","volume":"41","author":"Miyazaki","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaci.2004.10.042_bib19","first-page":"3041","article-title":"Prevention of allergic eye disease by treatment with IL-1 receptor antagonist","volume":"40","author":"Keane-Myers","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaci.2004.10.042_bib20","first-page":"336","article-title":"Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor-alpha from mast cells affects intercellular adhesion molecule 1 expression on epithelial cells","volume":"39","author":"Cook","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaci.2004.10.042_bib21","unstructured":"Miyazaki D, Nakamura T, Toda M, Ohbayashi M, Sherry B, Richardson RM, et al. Requirement of MIP1\u03b1 as an obligate costimulatory signal for mast cell degranulation in the conjunctiva. J Clin Invest. In press."},{"issue":"suppl 7","key":"10.1016\/j.jaci.2004.10.042_bib22","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00003226-200310001-00003","article-title":"Detailed criteria for the assessment of clinical symptoms in a new murine model of severe allergic conjunctivitis","volume":"22","author":"Nakamura","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jaci.2004.10.042_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0161-6420(02)01767-0","article-title":"Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis","volume":"110","author":"Leonardi","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2004.10.042_bib24","unstructured":"Nakamura T, Larkin F, Ikeda Y, Ohbayashi M, Toda M, Wilkins M, et al. CAT-213, a specific monoclonal anti-eotaxin-1 human antibody, inhibits human conjunctival mast cell activation. In: Immunology 2004. Bologna: Medimond International Proceedings; 2004. p. 527-30."},{"key":"10.1016\/j.jaci.2004.10.042_bib25","unstructured":"Toda, M, Nakamura T, Richardson RM, Ono SJ. Signaling-cross talk between Fc(epsilon)RI and CC chemokine receptor1 in mast cells. Immunology 2004, Medimond International Proceedings; 2004. p. 517-20."}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904030325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904030325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:55:38Z","timestamp":1758776138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674904030325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0091674904030325"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2004.10.042","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2004.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}